Engineering Toxin-Resistant Therapeutic Stem Cells to Treat Brain Tumors
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Engineering Toxin-Resistant Therapeutic Stem Cells to Treat Brain Tumors
Authors
Keywords
-
Journal
STEM CELLS
Volume 33, Issue 2, Pages 589-600
Publisher
Wiley
Online
2014-10-24
DOI
10.1002/stem.1874
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Understanding high grade glioma: Molecular mechanism, therapy and comprehensive management
- (2013) Yongzhi Wang et al. CANCER LETTERS
- BCL2A1is a lineage-specific antiapoptotic melanoma oncogene that confers resistance to BRAF inhibition
- (2013) Rizwan Haq et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Therapeutic stem cells expressing variants of EGFR-specific nanobodies have antitumor effects
- (2012) J. A. J. M. van de Water et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Current Review of in Vivo GBM Rodent Models: Emphasis on the CNS-1 Tumour Model
- (2011) Valerie L. Jacobs et al. ASN Neuro
- A guide to taming a toxin - recombinant immunotoxins constructed from Pseudomonas exotoxin A for the treatment of cancer
- (2011) John E. Weldon et al. FEBS Journal
- Histone modification enhances the effectiveness of IL-13 receptor targeted immunotoxin in murine models of human pancreatic cancer
- (2011) Toshio Fujisawa et al. Journal of Translational Medicine
- Encapsulated therapeutic stem cells implanted in the tumor resection cavity induce cell death in gliomas
- (2011) Timo M Kauer et al. NATURE NEUROSCIENCE
- A Dual PI3K/mTOR Inhibitor, PI-103, Cooperates with Stem Cell-Delivered TRAIL in Experimental Glioma Models
- (2010) T. Bagci-Onder et al. CANCER RESEARCH
- Phase III randomized trial of CED of IL13-PE38QQR vs Gliadel wafers for recurrent glioblastoma
- (2010) S. Kunwar et al. NEURO-ONCOLOGY
- Gene therapy-mediated delivery of targeted cytotoxins for glioma therapeutics
- (2010) M. Candolfi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Human Glioblastoma-Derived Cancer Stem Cells: Establishment of Invasive Glioma Models and Treatment with Oncolytic Herpes Simplex Virus Vectors
- (2009) H. Wakimoto et al. CANCER RESEARCH
- Phase II Trial of Recombinant Immunotoxin RFB4(dsFv)-PE38 (BL22) in Patients With Hairy Cell Leukemia
- (2009) Robert J. Kreitman et al. JOURNAL OF CLINICAL ONCOLOGY
- Assessment of therapeutic efficacy and fate of engineered human mesenchymal stem cells for cancer therapy
- (2009) L. S. Sasportas et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Oncogenic EGFR Signaling Networks in Glioma
- (2009) P. H. Huang et al. Science Signaling
- Interleukin-13 Receptor 2, EphA2, and Fos-Related Antigen 1 as Molecular Denominators of High-Grade Astrocytomas and Specific Targets for Combinatorial Therapy
- (2008) J. Wykosky et al. CLINICAL CANCER RESEARCH
- Stem and progenitor cell-mediated tumor selective gene therapy
- (2008) K S Aboody et al. GENE THERAPY
- Expression of glioma-associated antigens in pediatric brain stem and non-brain stem gliomas
- (2008) Hideho Okada et al. JOURNAL OF NEURO-ONCOLOGY
- Bimodal Viral Vectors and In Vivo Imaging Reveal the Fate of Human Neural Stem Cells in Experimental Glioma Model
- (2008) K. Shah et al. JOURNAL OF NEUROSCIENCE
- Therapeutic stem-cells for cancer treatment: hopes and hurdles in tactical warfare
- (2008) Maarten F Corsten et al. LANCET ONCOLOGY
- EGFR Antagonists in Cancer Treatment
- (2008) Fortunato Ciardiello et al. NEW ENGLAND JOURNAL OF MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started